BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11565065)

  • 1. Rubella seropositivity in the United States, 1988-1994.
    Dykewicz CA; Kruszon-Moran D; McQuillan GM; Williams WW; Van Loon FP; Cossen C; Forghani B; Hadler SC
    Clin Infect Dis; 2001 Oct; 33(8):1279-86. PubMed ID: 11565065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached?
    Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE
    Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.
    Hutchins SS; Redd SC; Schrag S; Kruszon-Moran D; Wooten K; McQuillan GM; Bellini W; Meyer PA; Hadler S
    MedGenMed; 2001 Jan; ():E5. PubMed ID: 11320344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran.
    Doroudchi M; Dehaghani AS; Emad K; Ghaderi AA
    East Mediterr Health J; 2001; 7(1-2):128-38. PubMed ID: 12596962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determining factors of rubella in the 10 to 14 year-old population in Mexico].
    Tapia-Conyer R; Sepúlveda J; Salvatierra B; Muńoz O; Bustamante-Calvillo E; Alvarez y Muńoz T; Gutiérrez G
    Salud Publica Mex; 1992; 34(2):211-21. PubMed ID: 1631734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of measles antibody in the US population, 1999-2004.
    McQuillan GM; Kruszon-Moran D; Hyde TB; Forghani B; Bellini W; Dayan GH
    J Infect Dis; 2007 Nov; 196(10):1459-64. PubMed ID: 18008224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella seroprevalence among women aged 15-39 years in Morocco.
    Caidi H; Bloom S; Azilmaat M; Benjouad A; Reef S; El Aouad R
    East Mediterr Health J; 2009; 15(3):526-31. PubMed ID: 19731768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination.
    Song N; Gao Z; Wood JG; Hueston L; Gilbert GL; MacIntyre CR; Quinn HE; Menzies R; McIntyre P
    Vaccine; 2012 Jun; 30(27):4073-8. PubMed ID: 22554644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The seroepidemiology of rubella in Mexican women. A national probability survey].
    Gutíerrez Trujillo G; Muñoz O; Tapia Conyer R; Bustamante Calvillo ME; Alvarez y Muñoz MT; Guiscafré Gallardo JP; Magos C; Sepúlveda J
    Salud Publica Mex; 1990; 32(6):623-31. PubMed ID: 2089638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of rubella antibodies among schoolgirls in Sana'a, Republic of Yemen.
    Sallam TA; Raja'a YA; Benbrake MS; Al-Shaibani KS; Al-Hababi AA
    East Mediterr Health J; 2003; 9(1-2):148-51. PubMed ID: 15562744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of rubella virus infection among female residents on the offshore islets of Taiwan.
    Lin DB; Chen CJ
    J Trop Med Hyg; 1994 Apr; 97(2):75-80. PubMed ID: 8170006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey.
    Yalcin A; Caliskan D; Isik A
    East Mediterr Health J; 2008; 14(5):1036-43. PubMed ID: 19161075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella seroprevalence among Turkish adolescent girls living in Edirne, Turkey.
    Oner N; Vatansever U; Karasalihoglu S; Tatman Otkun M; Ekuklu G; Küçükugurluoglu Y
    Turk J Pediatr; 2006; 48(4):288-93. PubMed ID: 17290561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current lessons from 20th century serosurveillance data on rubella.
    Cooper LZ
    Clin Infect Dis; 2001 Oct; 33(8):1287. PubMed ID: 11565066
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program.
    Wang IJ; Hwang KC; Tsai YH; Wu YN; Chao SJ; Chen TE; Huang LM
    Acta Paediatr Taiwan; 2006; 47(1):14-7. PubMed ID: 17016964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences.
    Majlessi F; Batebi A; Shariat M; Rahimi A; Azad TM
    East Mediterr Health J; 2008; 14(3):590-4. PubMed ID: 18720623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey.
    Valensin PE; Cusi MG; Zanchi A; Rossolini GM; Cellesi C; Amato T
    Microbiologica; 1988 Apr; 11(2):119-27. PubMed ID: 3405097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
    Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ
    J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.